BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16775241)

  • 1. Retinol-binding protein 4, insulin resistance, and type 2 diabetes.
    Polonsky KS
    N Engl J Med; 2006 Jun; 354(24):2596-8. PubMed ID: 16775241
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinol-binding protein 4 and insulin resistance.
    Erikstrup C; Mortensen OH; Pedersen BK
    N Engl J Med; 2006 Sep; 355(13):1393-4; author reply 1394-5. PubMed ID: 17014043
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism: A is for adipokine.
    Muoio DM; Newgard CB
    Nature; 2005 Jul; 436(7049):337-8. PubMed ID: 16034406
    [No Abstract]   [Full Text] [Related]  

  • 4. Retinol-binding protein 4 and insulin resistance.
    Oh J
    N Engl J Med; 2006 Sep; 355(13):1394; author reply 1394-5. PubMed ID: 17014044
    [No Abstract]   [Full Text] [Related]  

  • 5. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
    Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB
    N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinol-binding protein 4 and insulin resistance.
    Takashima N; Tomoike H; Iwai N
    N Engl J Med; 2006 Sep; 355(13):1392; author reply 1394-5. PubMed ID: 17005964
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.
    Cho YM; Youn BS; Lee H; Lee N; Min SS; Kwak SH; Lee HK; Park KS
    Diabetes Care; 2006 Nov; 29(11):2457-61. PubMed ID: 17065684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
    Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
    Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes.
    Wolf G
    Nutr Rev; 2007 May; 65(5):251-6. PubMed ID: 17566551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes: response to Cho et al.
    Gavi S; Qurashi S; Melendez MM; Mynarcik DC; McNurlan MA; Gelato MC
    Diabetes Care; 2007 Mar; 30(3):e7; author reply e8. PubMed ID: 17327302
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
    Kang L; Sebastian BM; Pritchard MT; Pratt BT; Previs SF; Nagy LE
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1581-8. PubMed ID: 17624994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new panorama for understanding the molecular connections between obesity and type 2 diabetes mellitus].
    Fernández-Mejía C
    Rev Invest Clin; 2001; 53(3):209-11. PubMed ID: 11496706
    [No Abstract]   [Full Text] [Related]  

  • 14. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
    Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
    Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
    Klein S; Fontana L; Young VL; Coggan AR; Kilo C; Patterson BW; Mohammed BS
    N Engl J Med; 2004 Jun; 350(25):2549-57. PubMed ID: 15201411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
    Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
    Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol-binding protein 4 in human obesity.
    Janke J; Engeli S; Boschmann M; Adams F; Böhnke J; Luft FC; Sharma AM; Jordan J
    Diabetes; 2006 Oct; 55(10):2805-10. PubMed ID: 17003346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinol-binding protein-4 in experimental and clinical metabolic disease.
    von Eynatten M; Humpert PM
    Expert Rev Mol Diagn; 2008 May; 8(3):289-99. PubMed ID: 18598108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.